Volume 6.30 | Aug 4

Hematopoiesis News 6.30 August 4, 2015
Hematopoiesis News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook   HN on Twitter
 
TOP STORY
An MTCH2 Pathway Repressing Mitochondria Metabolism Regulates Hematopoietic Stem Cell Fate
Scientists showed that loss of mitochondrial carrier homologue 2 (MTCH2) increases mitochondrial oxidative phosphorylation, triggering hematopoietic stem cell and progenitor entry into cycle. [Nat Commun] Abstract
Get Fresh Human Peripheral Whole Blood and Leuko Paks, Human Primary Cells
 
PUBLICATIONS (Ranked by impact factor of the journal)
Transmembrane TNF-α Preferentially Expressed by Leukemia Stem Cells and Blasts Is a Potent Target for Antibody Therapy
The authors demonstrated a role for transmembrane tumor necrosis factor-α (tmTNF-α) in leukemia. To characterize tmTNF-α expression in acute leukemia, normal hematopoietic cells, and non-hematopoietic tissues, they used a monoclonal antibody, termed C1, which specifically recognizes the tmTNF-α domain. [Blood] Abstract

C/EBPα Activates Pre-Existing and De Novo Macrophage Enhancers during Induced Pre-B Cell Transdifferentiation and Myelopoiesis
Scientists showed that during pre-B-cell-to-macrophage transdifferentiation, C/EBPα binds to two types of myeloid enhancers in B cells: pre-existing enhancers that are bound by PU.1, providing a platform for incoming C/EBPα; and de novo enhancers that are targeted by C/EBPα, acting as a pioneer factor for subsequent binding by PU.1. [Stem Cell Reports] Full Article | Graphical Abstract | Press Release

The Fanconi Anemia Pathway Is Required for Efficient Repair of Stress-Induced DNA Damage in Hematopoietic Stem Cells
Previously, the authors demonstrated such stress-associated DNA damage was sufficient to completely deplete hematopoietic stem cells and promote severe aplastic anemia (SAA) in the Fanconi anemia (FA) knockout mouse model, which has compromised replication-associated DNA repair. They extended this previous work to show that FA mice do not spontaneously develop a hematopoietic phenotype consistent with SAA, even at extreme old age. [Cell Cycle] Abstract

Impaired Hematopoiesis and Disrupted Monocyte/Macrophage Homeostasis in Mucopolysaccharidosis Type I Mice
Investigators evaluated alterations in hematopoiesis and its implications on the production of mature progeny in a mucopolysaccharidosis type I murine model. Despite the significant increase in hematopoietic stem cells, a reduction in common myeloid progenitors and granulocyte-macrophage progenitor cells was observed in Idua-/- mice bone marrow. [J Cell Physiol] Abstract

Non-Hematopoietic and Hematopoietic SIRPα Signaling Differently Regulates Murine B Cell Maturation in Bone Marrow and Spleen
Scientists provide evidence that signal regulatory protein alpha (SIRPα), an Ig-superfamily ITIM-receptor expressed by myeloid but not by lymphoid cells, is involved in regulating B cell maturation. [PLoS One] Full Article

CLINICAL RESEARCH

Outcome of Children with Acute Myeloid Leukemia (AML) Experiencing Primary Induction Failure in the AIEOP AML 2002/01 Clinical Trial
Investigators report the clinical and biological data, and final outcome of 48 pediatric patients with primary-resistant AML enrolled in the Associazione Italiana di Ematologia e Oncologia Pediatrica AML 2002/01 clinical trial. [Br J Haematol] Abstract

Allogeneic Hematopoietic Stem Cell Transplantation Could Improve Survival of Cytogenetically Normal Adult Acute Myeloid Leukemia Patients with DNMT3A Mutations
Researchers retrospectively analyzed the prognostic impact of DNMT3A mutations and explored the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in 308 cytogenetically normal acute myeloid leukemia patients who received consolidation of intensive chemotherapy or allo-HSCT. [Am J Hematol] Abstract

Extramedullary Hematopoiesis Is Associated with Lower Cardiac Iron Loading in Chronically Transfused Thalassemia Patients
Investigators evaluated in a large cohort of chronically transfused patients whether the presence of extramedullary hematopoiesis accounts for the typical patterns of cardiac iron distribution and/or cardiac function parameters. [Am J Hematol] Abstract

Anti-Thymocyte Globulin Could Improve the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Highly Aggressive T-Cell Tumors
Researchers used the anti-thymocyte globulin as the part of the conditioning regimen and evaluated the long-term anti-leukemia effect, the safety and complication in the patients with highly aggressive T-cell lymphomas. [Blood Cancer J] Full Article

Get More of the Cells You Need with StemSpan™ CD34+ Cell Expansion Supplement and StemSpan™ SFEM
 
REVIEWS
Innate Lymphoid Cells in Graft-versus-Host Disease
The authors summarize the current view of the immunological functions of human noncytotoxic innate lymphoid cell (ILC) subsets and discuss the potentially beneficial features of IL-22 producing ILC3 in improving allogeneic hematopoietic cell transplantation efficacy by attenuating susceptibility to graft-versus-host disease. [Am J Transplant] Full Article

Visit our reviews page to see a complete list of reviews in the hematopoiesis research field.
 
INDUSTRY NEWS
Kiadis Pharma Announces Full Enrollment of Its Phase II Clinical Study with Lead Product, ATIR101™
Kiadis Pharma N.V. announced full enrollment of patients into its ongoing Phase II clinical study with its lead product, ATIR101™. ATIR101™ is a cell-based product designed to enable stem cell transplantations from partially matched family donors for blood cancer patients who do not have a matching stem cell donor available. [Kiadis Pharma N.V.] Press Release

Juno Announces FDA Clearance of Investigational New Drug Application for JCAR015 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
Juno Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) cleared the company’s investigational new drug application for JCAR015 for treatment of adult patients with relapsed/refractory acute lymphoblastic leukemia. [Juno Therapeutics, Inc.] Press Release

Stem Cell Transplant Program Earns International Accreditation
The Stem Cell Transplant Program at the University of Virginia Cancer Center has received international accreditation for its use of stem cells and bone marrow to treat patients with blood cancers. [University of Virginia Cancer Center] Press Release

From our sponsor: Learn about detecting cancer stem cells with ALDEFLUOR™. Watch the webinar.
 
POLICY NEWS
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
 
EVENTS
NEW European Molecular Biology Laboratory (EMBL) Conference: Cancer Genomics
November 1-4, 2015
Heidelberg, Germany

Visit our events page to see a complete list of events in the hematopoiesis community.
 
JOB OPPORTUNITIES
NEW Postdoctoral Fellow – Hematopoiesis (University Hospital of Cologne)

Principal Scientist – Hematopoietic Products (STEMCELL Technologies Inc.)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)

Postdoctoral Fellow – Hematopoietic Regeneration and Myeloid Malignancies (Weill-Cornell Medical College)

Postdoctoral Position – Hematopoietic Stem and Progenitor Cell Assays (Weill Cornell Medical School)

Research Associate – Cell Biology (Editas Medicine)

Postdoctoral Position – Splicing in Hematopoiesis (Northwestern University)

Clinical Research Coordinator – Chronic Lymphocytic Leukemia (Fred Hutchinson Cancer Research Center)

Postdoctoral Position – Hematopoietic Stem Cell Transplantation (St. Jude Children’s Research Hospital)

Postdoctoral Position – Hematopoietic Stem Cell and Hematologic Malignancy (University of Kentucky College of Medicine)


Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
 

Have we missed an important article or publication in Hematopoiesis News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Hematopoiesis News: Archives | Events | Contact Us